Timofey Lebedev

627 total citations
48 papers, 426 citations indexed

About

Timofey Lebedev is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Timofey Lebedev has authored 48 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Neurology and 9 papers in Genetics. Recurrent topics in Timofey Lebedev's work include Neuroblastoma Research and Treatments (12 papers), Virus-based gene therapy research (8 papers) and Protein Degradation and Inhibitors (6 papers). Timofey Lebedev is often cited by papers focused on Neuroblastoma Research and Treatments (12 papers), Virus-based gene therapy research (8 papers) and Protein Degradation and Inhibitors (6 papers). Timofey Lebedev collaborates with scholars based in Russia, Germany and United States. Timofey Lebedev's co-authors include Vladimir Prassolov, Pavel Spirin, Anton Buzdin, П. М. Рубцов, Carol Stocking, M. M. Prokofjeva, В. И. Попенко, Н. А. Никитенко, Maxim Sorokin and Sergey E. Dmitriev and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Scientific Reports.

In The Last Decade

Timofey Lebedev

45 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timofey Lebedev Russia 12 286 86 71 60 46 48 426
Latika Kohli United States 8 278 1.0× 43 0.5× 79 1.1× 50 0.8× 67 1.5× 9 476
Daisy Lio Australia 10 365 1.3× 99 1.2× 19 0.3× 111 1.9× 45 1.0× 16 541
Paulo H. Godoi Brazil 14 298 1.0× 17 0.2× 44 0.6× 49 0.8× 16 0.3× 20 420
M. A. Kaetzel United States 10 527 1.8× 46 0.5× 83 1.2× 22 0.4× 45 1.0× 12 605
Ann Kari Grindheim Norway 9 254 0.9× 22 0.3× 91 1.3× 26 0.4× 22 0.5× 14 311
Peter Göttig Germany 6 335 1.2× 44 0.5× 53 0.7× 16 0.3× 32 0.7× 7 358
Yuko Murakami‐Tonami Japan 14 385 1.3× 41 0.5× 57 0.8× 68 1.1× 10 0.2× 25 493
Chiara Soncini Italy 8 352 1.2× 30 0.3× 39 0.5× 139 2.3× 68 1.5× 9 580
Ke Wan China 8 658 2.3× 53 0.6× 28 0.4× 89 1.5× 34 0.7× 18 797
Sang‐Min Jang South Korea 16 507 1.8× 26 0.3× 106 1.5× 126 2.1× 17 0.4× 44 634

Countries citing papers authored by Timofey Lebedev

Since Specialization
Citations

This map shows the geographic impact of Timofey Lebedev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timofey Lebedev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timofey Lebedev more than expected).

Fields of papers citing papers by Timofey Lebedev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timofey Lebedev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timofey Lebedev. The network helps show where Timofey Lebedev may publish in the future.

Co-authorship network of co-authors of Timofey Lebedev

This figure shows the co-authorship network connecting the top 25 collaborators of Timofey Lebedev. A scholar is included among the top collaborators of Timofey Lebedev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timofey Lebedev. Timofey Lebedev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Кондакова, И. В., С. В. Вторушин, Pavel Spirin, et al.. (2025). Association of Proteasome Activity and Pool Heterogeneity with Markers Determining the Molecular Subtypes of Breast Cancer. Cancers. 17(1). 159–159. 2 indexed citations
2.
Spirin, Pavel, А. В. Морозов, Yuri B. Porozov, et al.. (2025). New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis. Pharmaceutics. 17(4). 416–416.
3.
Yusubalieva, Gaukhar M., Pavel N. Solyev, Anastasiya V. Lipatova, et al.. (2025). Piperazine-Substituted Pyranopyridines Exhibit Antiproliferative Activity and Act as Inhibitors of HBV Virion Production. International Journal of Molecular Sciences. 26(9). 3991–3991. 1 indexed citations
4.
Lebedev, Timofey, et al.. (2025). Systematic Comparison of FBS and Medium Variation Effect on Key Cellular Processes Using Morphological Profiling. Cells. 14(5). 336–336. 1 indexed citations
5.
6.
Lebedev, Timofey, et al.. (2023). Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells. 12(6). 952–952. 10 indexed citations
7.
Kamashev, Dmitri, Timofey Lebedev, Vladimir Prassolov, et al.. (2023). Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways. Cells. 12(16). 2022–2022. 5 indexed citations
8.
He, Miao, Timofey Lebedev, Y. George Zheng, et al.. (2022). PRMT1 is an important factor for medulloblastoma cell proliferation and survival. Biochemistry and Biophysics Reports. 32. 101364–101364. 7 indexed citations
9.
Lebedev, Timofey, et al.. (2021). Plasmolipin and Its Role in Cell Processes. Molecular Biology. 55(6). 773–785. 12 indexed citations
10.
Lebedev, Timofey, et al.. (2021). Плазмолипин и его роль в клеточных процессах. Молекулярная биология. 55(6). 883–896. 1 indexed citations
11.
Funikov, S. Yu., Timofey Lebedev, В. И. Попенко, et al.. (2021). A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes. Cells. 10(11). 3049–3049. 4 indexed citations
12.
Lebedev, Timofey, et al.. (2021). Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis. Scientific Reports. 11(1). 11234–11234. 37 indexed citations
13.
Lebedev, Timofey, et al.. (2021). Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis. Scientific Reports. 11(1). 17658–17658. 1 indexed citations
14.
15.
16.
Prokofjeva, M. M., Г. М. Прошкина, Timofey Lebedev, et al.. (2017). Lentiviral gene delivery to plasmolipin-expressing cells using Mus caroli endogenous retrovirus envelope protein. Biochimie. 142. 226–233. 4 indexed citations
17.
18.
19.
Lebedev, Timofey, et al.. (2013). RNA interference and deep sequencing as tools for identifying new genes involved in leukemogenesis. Doklady Biochemistry and Biophysics. 448(1). 49–51. 4 indexed citations
20.
Lebedev, Timofey, Pavel Spirin, & Vladimir Prassolov. (2013). Transfer and Expression of Small Interfering RNAs in Mammalian Cells Using Lentiviral Vectors. Acta Naturae. 5(2). 7–18. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Latika Kohli Breakdown of academic impact, for papers by Daisy Lio Breakdown of academic impact, for papers by Paulo H. Godoi Breakdown of academic impact, for papers by M. A. Kaetzel Breakdown of academic impact, for papers by Ann Kari Grindheim Breakdown of academic impact, for papers by Peter Göttig Breakdown of academic impact, for papers by Yuko Murakami‐Tonami Breakdown of academic impact, for papers by Chiara Soncini Breakdown of academic impact, for papers by Ke Wan Breakdown of academic impact, for papers by Sang‐Min Jang
Rankless by CCL
2026